BIOEMTECH

BIOEMTECH accelerates preclinical drug development toward clinical translation through specialized research services and innovative imaging technologies. Its boutique laboratories support preclinical studies including in vitro assays, molecular imaging, radionuclide therapy, dosimetry and GLP toxicology. BIOEMTECH also develops the eyes™ desktop cameras for real-time in vivo imaging of radionuclides and dyes, including alpha emitters such as ²¹²Pb and ²²⁵Ac, enabling fast screening and efficient translational research.

www.bioemtech.com

BIOEMTECH-2
BIOEMTECH-2